1. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022) Authors: Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;... Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study. Issue 3 (4th May 2017) Authors: Forns, Xavier; Berenguer, Marina; Herzer, Kerstin; Sterneck, Martina; Donato, Maria Francesca; Andreone, Pietro; Fagiuoli, Stefano; Cieciura, Tomasz; Durlik, Magdalena; Calleja, Jose Luis; Mariño, Zoe; Shukla, Umesh; Verbinnen, Thierry; Lenz, Oliver; Ouwerkerk‐Mahadevan, Sivi; Peeters, Monika; Ja... Journal: Transplant infectious disease Issue: Volume 19:Issue 3(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Once‐daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment‐naïve genotype 1 hepatitis C: The randomized PILLAR study. Issue 6 (11th October 2013) Authors: Fried, Michael W.; Buti, Maria; Dore, Gregory J.; Flisiak, Robert; Ferenci, Peter; Jacobson, Ira; Marcellin, Patrick; Manns, Michael; Nikitin, Igor; Poordad, Fred; Sherman, Morris; Zeuzem, Stefan; Scott, Jane; Gilles, Leen; Lenz, Oliver; Peeters, Monika; Sekar, Vanitha; De, Goedele; Beumont‐Mauvi... Journal: Hepatology Issue: Volume 58:Issue 6(2013:Dec.) Page Start: 1918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Simeprevir plus peginterferon/ribavirin for HCV genotype 1‐infected treatment‐naïve patients in China and South Korea. Issue 5 (May 2016) Authors: Wei, Lai; Han, Tao; Yang, Dongliang; Heo, Jeong; Shang, Jia; Cheng, Jun; Chen, Xinyue; Xie, Qing; Kim, Ju‐Hyun; Kalmeijer, Ronald; Ouwerkerk‐Mahadevan, Sivi; Hoeben, Eva; Lenz, Oliver; Verbinnen, Thierry; Sinha, Rekha; Li, MengChun; Scott, Jane; Peeters, Monika; Witek, James Journal: Journal of gastroenterology and hepatology Issue: Volume 31:Issue 5(2016:May) Page Start: 912 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1‐infected patients without cirrhosis: OPTIMIST‐1, a phase 3, randomized study. Issue 2 (22nd March 2016) Authors: Kwo, Paul; Gitlin, Norman; Nahass, Ronald; Bernstein, David; Etzkorn, Kyle; Rojter, Sergio; Schiff, Eugene; Davis, Mitchell; Ruane, Peter; Younes, Ziad; Kalmeijer, Ronald; Sinha, Rekha; Peeters, Monika; Lenz, Oliver; Fevery, Bart; De La Rosa, Guy; Scott, Jane; Witek, James Journal: Hepatology Issue: Volume 64:Issue 2(2016:Aug.) Page Start: 370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2). Issue 2 (19th February 2016) Authors: Lawitz, Eric; Matusow, Gary; DeJesus, Edwin; Yoshida, Eric M.; Felizarta, Franco; Ghalib, Reem; Godofsky, Eliot; Herring, Robert W.; Poleynard, Gary; Sheikh, Aasim; Tobias, Hillel; Kugelmas, Marcelo; Kalmeijer, Ronald; Peeters, Monika; Lenz, Oliver; Fevery, Bart; De La Rosa, Guy; Scott, Jane; Sin... Journal: Hepatology Issue: Volume 64:Issue 2(2016:Aug.) Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The effect of single‐ and multiple‐dose etravirine on a drug cocktail of representative cytochrome P450 probes and digoxin in healthy subjects. (19th November 2013) Authors: Kakuda, Thomas N.; Van Solingen‐Ristea, Rodica M.; Onkelinx, Joelle; Stevens, Tanja; Aharchi, Fatima; De Smedt, Goedele; Peeters, Monika; Leopold, Lorant; Hoetelmans, Richard M.W. Journal: Journal of clinical pharmacology Issue: Volume 54:Number 4(2014:Apr.) Page Start: 422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The impact of baseline characteristics on virologic response to etravirine: 48-week pooled analysis of DUET-1 and DUET-2. Issue 5 (September 2010) Authors: Cahn, Pedro; Haubrich, Richard; Katlama, Christine; Goebel, Frank; Suter, Fredy; Peeters, Monika; Vingerhoets, Johan; Sinha, Rekha; Witek, James Journal: HIV therapy Issue: Volume 4:Issue 5(2010) Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗